Keraplast Manufacturing — Form D
Keraplast Manufacturing of LINCOLN, Q2, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-21. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-21
- Form: D
- Accession: 0002012473-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.3M
- Amount sold: $1.3M
- Minimum investment: $1.3M
- Investors: 1
- Date of first sale: 2023-12-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505714
Issuer
- Name: Keraplast Manufacturing
- CIK: 0002012473
- Entity type: Other
- Jurisdiction: NEW ZEALAND
- Address: CORNER OF SPRINGS ROAD AND GERALD ST., LINCOLN, Q2, 7608
- Phone: 033259100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Timothy Howard Herring | Director | San Antonio, TX |
| Edward Shihai Lee | Director | ONTARIO, CA |
| Howard Stanley Moore | Director | Mangawhai, Q2 |
| Michael William Shea | Director | Auckland, Q2 |
| Robert Allen Smith | Director | Ridgeland, MS |
| Howard Stanley Moore | Executive Officer | Mangawhai, Q2 |
More